Chemours (CC)
(Delayed Data from NYSE)
$19.44 USD
+0.10 (0.52%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $19.44 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
D Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.44 USD
+0.10 (0.52%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $19.44 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
D Value F Growth D Momentum F VGM
Zacks News
Chemours (CC) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Chemours (CC) delivered earnings and revenue surprises of 6.90% and 0.31%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Chemours (CC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Chemours (CC) closed at $28.77 in the latest trading session, marking a -1.34% move from the prior day.
Earnings Preview: Methanex (MEOH) Q3 Earnings Expected to Decline
by Zacks Equity Research
Methanex (MEOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemours (CC) to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
While Chemours (CC) is likely to have benefited from healthy demand and pricing actions, raw material inflation and ore logistics constraints are expected to have affected its performance.
Earnings Preview: Chemours (CC) Q3 Earnings Expected to Decline
by Zacks Equity Research
Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemours (CC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Chemours (CC) closed the most recent trading day at $26.53, moving -1.38% from the previous trading session.
Chemours (CC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Chemours (CC) closed the most recent trading day at $24.50, moving +1.66% from the previous trading session.
Are Options Traders Betting on a Big Move in Chemours (CC) Stock?
by Zacks Equity Research
Investors need to pay close attention to Chemours (CC) stock based on the movements in the options market lately.
Chemours (CC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Chemours (CC) closed the most recent trading day at $24.10, moving +0.67% from the previous trading session.
Here's Why You Should Hold Onto Chemours (CC) Stock for Now
by Zacks Equity Research
While Chemours (CC) is exposed to supply-chain issues and higher input costs, it gains on healthy demand, strong execution and its cost-reduction and pricing actions.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Company News for Sep 22, 2022
by Zacks Equity Research
Companies in The News Are: GIS,BYND,COTY,CC
FMC Corp (FMC) Gains on Strong Demand Amid Cost Headwinds
by Zacks Equity Research
FMC Corp (FMC) benefits from higher demand for its products, its portfolio strength and contributions of new products amid currency and input cost headwinds.
Sociedad Quimica (SQM) Shares Rally 108% YTD: What's Driving It?
by Zacks Equity Research
Sociedad Quimica (SQM) gains on higher prices across its business lines and healthy demand.
Zacks Industry Outlook Highlights Albemarle, The Chemours, Univar Solutions and Innospec
by Zacks Equity Research
Albemarle, The Chemours, Univar Solutions and Innospec have been highlighted in this Industry Outlook article.
4 Stocks to Buy From the Prospering Diversified Chemical Industry
by Anindya Barman
A recovery in demand in major end markets should enable the Zacks Chemicals Diversified industry to thrive. ALB, CC, UNVR and IOSP are set to gain from favorable industry fundamentals and strategic actions to counter cost inflation.
Chemours (CC) Stock Moves -0.38%: What You Should Know
by Zacks Equity Research
Chemours (CC) closed the most recent trading day at $33.81, moving -0.38% from the previous trading session.
Why You Should Add Ashland (ASH) Stock to Your Portfolio
by Zacks Equity Research
Ashland (ASH) gains on strong demand in its consumer end markets and its pricing actions to counter inflation.
Ingevity (NGVT) Gains on Demand Strength and Growth Actions
by Zacks Equity Research
Ingevity (NGVT) benefits from strength in its engineered polymers and industrial specialties businesses and actions to drive growth.
5 Top-Notch Dividend Plays in the Diversified Chemical Industry
by Anindya Barman
Against the current volatile macroeconomic backdrop, it would be prudent to add some top-quality dividend-paying chemical stocks in your portfolio. CC, CBT, HUN, LYB and TROX fit the bill.
Is Chemours (CC) Outperforming Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Chemours (CC) and SQM (SQM) have performed compared to their sector so far this year.
Is Chemours (CC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CC vs. PPG: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CC vs. PPG: Which Stock Is the Better Value Option?
Chemours (CC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Chemours (CC), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Harmony's (HMY) Earnings Down, Revenues Increase Y/Y in FY22
by Zacks Equity Research
Harmony (HMY) benefits from higher year over year average gold prices despite a decline in production in fiscal 2022.